EMA Publishes New Guidance on Rheumatoid Arthritis Drug Trials

Drug Industry Daily
A A
The European Medicines Agency updated guidance on clinical investigations of rheumatoid arthritis drugs to add new endpoints and distinguish between patient subgroups in trials.

To View This Article:

Login

Subscribe To Drug Industry Daily